The research, published on November 13 in The study, which included around 228,000 people in Sweden, showed a 36% lower risk of hospitalization among those taking semaglutide
Long-term all-cause and cause-specific mortality for four bariatric surgery procedures
Actionable Tip from the National Health Service (NHS) Keep a water bottle with you at all times and sip consistently throughout the day, even if you don't feel thirsty
FDA's April 2026 proposal to remove semaglutide and tirzepatide from the 503B bulks list - with a public comment period through June 2026 - creates a genuine decision window: buyers who enroll now are committing to a subscription before the outcome of that proposal is known
However, there are some more serious side effects to be aware of, such as pancreatitis (inflammation of the pancreas) and thyroid tumors, although these are rare
GLP-1 therapy should complement, not replace, appropriate lipid-lowering treatment according to NICE guidance